AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
68.55
+0.19 (0.28%)
At close: Apr 19, 2024, 4:00 PM
68.51
-0.04 (-0.06%)
After-hours: Apr 19, 2024, 7:44 PM EDT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $212.49 billion as of April 19, 2024. Its market cap has decreased by -8.31% in one year.
Market Cap
212.49B
Enterprise Value
235.15B
1-Year Change
-8.31%
Ranking
Category
Stock Price
$68.55
Market Cap Chart
Since November 21, 2000, AstraZeneca's market cap has increased from $63.18B to $212.49B, an increase of 236.35%. That is a compound annual growth rate of 5.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 212.53B | 0.28% |
Apr 18, 2024 | 211.94B | -0.25% |
Apr 17, 2024 | 212.47B | 0.39% |
Apr 16, 2024 | 211.64B | -0.68% |
Apr 15, 2024 | 213.09B | -0.29% |
Apr 12, 2024 | 213.71B | -0.75% |
Apr 11, 2024 | 215.32B | 1.97% |
Apr 10, 2024 | 211.16B | -0.44% |
Apr 9, 2024 | 212.09B | 1.05% |
Apr 8, 2024 | 209.89B | 0.37% |
Apr 5, 2024 | 209.12B | 0.16% |
Apr 4, 2024 | 208.78B | 0.79% |
Apr 3, 2024 | 207.13B | -0.28% |
Apr 2, 2024 | 207.72B | -0.37% |
Apr 1, 2024 | 208.50B | -0.74% |
Mar 28, 2024 | 210.05B | -0.75% |
Mar 27, 2024 | 211.63B | 2.91% |
Mar 26, 2024 | 205.64B | 0.71% |
Mar 25, 2024 | 204.19B | -0.60% |
Mar 22, 2024 | 205.43B | 0.11% |
Mar 21, 2024 | 205.21B | 0.70% |
Mar 20, 2024 | 203.78B | -0.20% |
Mar 19, 2024 | 204.19B | 0.02% |
Mar 18, 2024 | 204.16B | -0.69% |
Mar 15, 2024 | 205.58B | -1.09% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Novo Nordisk | 564.13B |
UnitedHealth Group | 441.60B |
Johnson & Johnson | 348.72B |
Merck & Co. | 317.52B |
AbbVie | 290.83B |
Thermo Fisher | 208.89B |
Abbott Laboratories | 183.76B |
Novartis AG | 182.11B |